- M.D., University of Massachusetts Medical School
- Residency, Neurology, University of Virginia
- Fellowship, Electrophysiology Neurology, University of Utah
Department of Neurological Sciences
BIO
Dr. Noah Kolb is a Professor of Neurological Science and the Robert Larner College of Medicine at the University of Vermont. He is a neuromuscular neurologist caring for patients with a wide spectrum of neurologic disorders including Myasthenia gravis, ALS, Muscular Dystrophy, CIDP and other forms of Neuropathy. To aid in the diagnoses of these and other disorders he also performs electromyography (EMG/ NCS). Dr. Kolb leads a research team focused on answering the central questions about nerve damage from chemotherapy called chemotherapy induced peripheral neuropathy and has additional research projects in other neuromuscular diseases. His career is also dedicated to teaching and education. At LCOM he directs the neurological education program for 3rd and 4th year medical students. Nationally, he lectures about a variety of neuromuscular topics. (see below for further details)
Dr. Kolb's research work is focused primarily on nerve damage caused from chemotherapy called chemotherapy induced peripheral neuropathy (CIPN). Led by Dr. Kolb, his research team investigates the causes, treatments and preventative strategies for CIPN including large multi-center NIH funded randomized controlled trials. While CIPN is his focus, he has other active ongoing research projects in ALS, MG, CIDP and painful neuropathy. At LCOM, Dr. Kolb is a member of the LCOM Teaching Academy and serves as the Director of the Neurology Clerkship and Acting Internship for the 3rd and 4th year medical students respectively. Through this and engagement in the Doctoring in Vermont, Premedical Enhancement Program, Neurology Residency and UVM Neuromuscular Fellowship Dr. Kolb mentors learners from high school through early academic neurologists. Nationally, Dr. Kolb lectures about neuropathy and other neuromuscular topics in his field.
Publications
Awards and Achievements
- Robert Larner College of Medicine Deans’s Excellence in Research Award for a Mid-Career Investigator (2023)
Bio
Dr. Noah Kolb is a Professor of Neurological Science and the Robert Larner College of Medicine at the University of Vermont. He is a neuromuscular neurologist caring for patients with a wide spectrum of neurologic disorders including Myasthenia gravis, ALS, Muscular Dystrophy, CIDP and other forms of Neuropathy. To aid in the diagnoses of these and other disorders he also performs electromyography (EMG/ NCS). Dr. Kolb leads a research team focused on answering the central questions about nerve damage from chemotherapy called chemotherapy induced peripheral neuropathy and has additional research projects in other neuromuscular diseases. His career is also dedicated to teaching and education. At LCOM he directs the neurological education program for 3rd and 4th year medical students. Nationally, he lectures about a variety of neuromuscular topics. (see below for further details)
Dr. Kolb's research work is focused primarily on nerve damage caused from chemotherapy called chemotherapy induced peripheral neuropathy (CIPN). Led by Dr. Kolb, his research team investigates the causes, treatments and preventative strategies for CIPN including large multi-center NIH funded randomized controlled trials. While CIPN is his focus, he has other active ongoing research projects in ALS, MG, CIDP and painful neuropathy. At LCOM, Dr. Kolb is a member of the LCOM Teaching Academy and serves as the Director of the Neurology Clerkship and Acting Internship for the 3rd and 4th year medical students respectively. Through this and engagement in the Doctoring in Vermont, Premedical Enhancement Program, Neurology Residency and UVM Neuromuscular Fellowship Dr. Kolb mentors learners from high school through early academic neurologists. Nationally, Dr. Kolb lectures about neuropathy and other neuromuscular topics in his field.
Publications
Awards and Achievements
- Robert Larner College of Medicine Deans’s Excellence in Research Award for a Mid-Career Investigator (2023)
Select Publications
- Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S, Mooney K. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling. JAMA Neurol. 2016 Jul 1;73(7):860-6. doi: 10.1001/jamaneurol.2016.0383. PMID: 27183099; PMCID: PMC6715416.
- Kolb NA, Smith AG, Singleton JR, Beck SL, Howard D, Dittus K, Karafiath S, Mooney K. Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up. Support Care Cancer. 2018 May;26(5):1607-1615. doi: 10.1007/s00520-017-3970-7. Epub 2017 Dec 5. PMID: 29204710.
- McNeish BL, Kolb N. Toxic Neuropathies. Continuum (Minneap Minn). 2023 Oct 1;29(5):1444-1468. doi: 10.1212/CON.0000000000001343. PMID: 37851038.
- McNeish BL, Dittus K, Mossburg J, Krant N, Steinharter JA, Feb K, Cote H, Hehir MK, Reynolds R, Redfern MS, Rosano C, Richardson JK, Kolb N. The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
- J Geriatr Oncol. 2024 May;15(4):101765. doi: 10.1016/j.jgo.2024.101765. Epub 2024 Apr 5. PMID: 38581957; PMCID: PMC11088516.
- Hehir MK, Conaway M, St Sauveur AB, Feb K, Kolb NA, Waheed W, McNeish BL, Tweedy N, Burns TM. Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU). Muscle Nerve. 2024 Jan;69(1):32-39. doi: 10.1002/mus.27966. Epub 2023 Sep 7. PMID: 37676119.